A critical breakthrough in cancer investigation is occurring with the use of mini-antibodies to re-engage damaged p53. This vital cancer inhibitor protein is frequently inactivated in many kinds of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research